Latest newsLATEST NEWS

We aim to become one of the leading pharmaceutical companies and to do all in our power to help prevent infectious diseases.

2019/03/05
MVC Enters Strategic Cell Therapy Alliance with MBC and TaiwanBio Therapeutics
see more
2019/02/11
MVC's Aseptic Filling Line Obtained TFDA's PIC/S GMP Certification
see more
2018/11/30
MVC Obtains PIC/S GMP Certification
see more
2018/10/02
MVC Receives TFDA's Approval to Start Phase 3 Clinical Trial of Quadrivalent Influenza Vaccine
see more
2018/05/03
To Ease Local Measles Outbreak, MVC Signed MoU with SII
see more
2018/04/23
Medigen Vaccine Biologics Corp. and GC Pharma (GCC) Collaborate to Commercialize Quadrivalent Influenza Vaccine in Taiwan
see more
We use cookies to improve your user experience and for web traffic statistics purposes. By continuing to use this website, you agree to our use of cookies. Our Privacy & Cookie Policy contains more information on such use and explains how to disable cookies.
Agree